Future Market Insights2h
Global Direct Oral Anticoagulants Market Projected to Reach USD 71.78 Billion by 2032, Driven by FDA Approvals and Rising Thrombosis Cases
One of the primary factors fueling the growth of the DOACs market is the rapid uptake and expected utilization within the ...
Stock World4h
EQS-News: QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery
QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery. Strategic partnership with the Research Institute of Molecular Patholog ...
PharmiWeb4h
QUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery
AllianceQUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery 24.10.2024 / 09:30 CET/CESTThe issuer is solely responsible for the content of this ...
Roche comes out against allowing takeover of drug manufacturer Catalent
The CEO of pharmaceuticals giant Roche said authorities should block the takeover of contract drug manufacturer Catalent by ...
Future Market Insights21h
Global Hidradenitis Suppurativa Treatment Market Projected to Reach USD 1,240.9 Million by 2033, With a CAGR of 4.97%
Boehringer Ingelheim, Eli Lilly, Moonlake Immunotherapeutics, and Aristea Therapeutics. Sabyasachi Ghosh (Associate Vice ...
PharmiWeb23h
Global Progressive Fibrosing Interstitial Lung Disease Market Projected to Reach USD 8654.1 Million by 2033 at a 6.2% of CAGR
The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...